| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-13 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.29 | 7e-11 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |